BEECHAM PHARM PTE LTD has a total of 82 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States, EPO (European Patent Office) and United Kingdom. Its main competitors in its focus markets pharmaceuticals are NYCOMED DANMARK APS, DIZLIN PHARMACEUTICALS AB and COSMO TECH LIMITED.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | United Kingdom | 4 | |
#4 | Australia | 3 | |
#5 | Israel | 3 | |
#6 | New Zealand | 3 | |
#7 | WIPO (World Intellectual Property Organization) | 3 | |
#8 | Belgium | 2 | |
#9 | Brazil | 2 | |
#10 | Canada | 2 | |
#11 | China | 2 | |
#12 | Czechia | 2 | |
#13 | Hungary | 2 | |
#14 | Mexico | 2 | |
#15 | Netherlands | 2 | |
#16 | Norway | 2 | |
#17 | Poland | 2 | |
#18 | South Africa | 2 | |
#19 | African Regional Industrial Property Organization | 1 | |
#20 | Argentina | 1 | |
#21 | Bulgaria | 1 | |
#22 | Germany | 1 | |
#23 | Denmark | 1 | |
#24 | Algeria | 1 | |
#25 | EAPO (Eurasian Patent Organization) | 1 | |
#26 | Spain | 1 | |
#27 | Finland | 1 | |
#28 | France | 1 | |
#29 | Gulf Cooperation Council | 1 | |
#30 | Greece | 1 | |
#31 | Hong Kong | 1 | |
#32 | Ireland | 1 | |
#33 | Morocco | 1 | |
#34 | Malaysia | 1 | |
#35 | Peru | 1 | |
#36 | Portugal | 1 | |
#37 | Romania | 1 | |
#38 | Sweden | 1 | |
#39 | Slovenia | 1 | |
#40 | Slovakia | 1 | |
#41 | Taiwan | 1 | |
#42 | Uruguay | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Roush John A | 35 |
#2 | Storm Kevin | 34 |
#3 | Conley Creighton P | 34 |
#4 | Storm Kevin H | 33 |
#5 | Conley Creighton | 31 |
#6 | Roush John | 31 |
#7 | Conley Creighton Pierce | 2 |
#8 | Storm K H | 1 |
#9 | Creighton Conley | 1 |
#10 | Conley Cheighton P | 1 |
Publication | Filing date | Title |
---|---|---|
GB0313913D0 | New use | |
US2003224049A1 | Amoxicillin and potassium clavulanate dosage form | |
GB0218422D0 | New use | |
GB0218423D0 | Novel compositions | |
GB0216993D0 | Novel compositions | |
ZA200108322B | Novel method of treatment. | |
EP1330236A2 | Formulation containing amoxicillin | |
US7250176B1 | Method of treating a bacterial infection | |
GC0000336A | Pharmaceutical formulation comprising amoxycillin and clavulanate for the treatment of drug resistant s.pneumoniae | |
IL145580D0 | A modified release pharmaceutical composition comprising amoxycillin and potassium clavulanate | |
CN1373664A | Therapeutic method | |
US6878386B1 | Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate | |
US6294199B1 | Method of treating a bacterial infection comprising administering amoxycillin |